AxoSim is a biotech company specializing in the development of neurological drugs. It offers the Nerve-on-a-Chip platform that facilitates the prediction of both clinical neurotoxicity and efficacy in human neurodegenerative disease models in the drug development pipeline. In addition, the company provides the Mini Brain, a 3D miniature brain organoid designed to serve as a human-relevant model in preclinical drug discovery.